Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Award of share options

16 May 2014 11:33

RNS Number : 3469H
Ebiquity PLC
16 May 2014
 



Ebiquity plc

("Ebiquity" or the "Company")

Award of share options

 

The Company announces that the following options (the "Options") to acquire ordinary shares of 25p each in the Company ("Ordinary Shares") have been issued to the directors listed below. The exercise price of each Option is 25p per Ordinary Share.

Name of director

Number of options

Michael Greenlees

800,000

Nicholas Manning

200,000

Andrew Beach

60,000

 

The vesting of the Options will be conditional on the satisfaction of performance criteria.

 

The entire Options granted to Nicholas Manning and Andrew Beach and 300,000 of the Options granted to Michael Greenlees under the Company's Executive Incentive Plan ("EIP Options") will vest according to the rate of compound growth of the Company's diluted adjusted earnings per share ("EPS") over the three year period ending 30 April 2017 (the "Performance Period"). Growth will be measured against the reference adjusted diluted EPS for the year ended 30 April 2014. Compound EPS growth over the Performance Period of 10% per annum or more will result in all of the EIP Options vesting. Compound EPS growth of 4% per annum over the Performance Period will vest one fifth of the EIP Options. Compound EPS growth of 8% per annum over the Performance Period will vest three fifths of the EIP Options. None of the EIP Options will vest if compound EPS growth over the Performance Period is less than 4% per annum. The EIP Options will vest on a straight-line basis between the 4%, 8% and 10% thresholds.

 

The additional 500,000 options granted to Michael Greenlees ("LTIP Options") will vest according to the rate of annual growth in the Total Shareholder Returns ("TSR") over a 3-year period, with 30% capable of vesting according to the average share price in the 20 trading days immediately following the preliminary announcement of results for the year to 30 April 2015 (relative to the 20 trading days prior to 30 April 2014), 35% for the year to 30 April 2016 and 35% to 30 April 2017. TSR growth of 12% will result in all of the LTIP Options vesting, with one quarter of the LTIP Options vesting on TSR growth of 4% and one half vesting on TSR growth of 8% with straight line allocation between these thresholds. Any unvested amounts in year 1 and 2 will roll forward to the following year(s) so that all LTIP Options are available to vest in subsequent years relative to compound TSR growth over the cumulative period. Any unvested LTIP Options may also vest at the end of year 3 if, despite TSR performance, the Company's TSR for the three-year period is in the top quartile of TSR performance for the AIM media index, with full vesting if the compound EPS growth is 8% or over, no vesting if the compound EPS growth is 4% or under and a straight-line allocation if EPS growth is between 4 and 8%.

 

Director's shareholding

 

Further to the announcement made by the Company on 25 March 2014 relating to the exercise of certain share options by Andrew Beach, the Company confirms that Mr Beach holds an interest in 209,476 Ordinary Shares representing approximately 0.3% of the Company's total voting rights.

 

Total voting rights

 

The Company's issued share capital consists of 75,491,111 Ordinary Shares and a total of 71,291,111 voting rights.

 

The Ebiquity plc 2000 Employee Benefit Trust holds 4,200,000 issued Ordinary Shares to satisfy awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Ordinary Shares held by it. As such 4,200,000 Ordinary Shares are treated as not carrying voting rights for the purposes of the City Code on Takeovers and Mergers

 

16 May 2014

 

ENQUIRIES:

 

Ebiquity

020 7650 9600

Michael Greenlees, CEO

Andrew Beach, CFO

Instinctif Partners

020 7457 2020

Matthew Smallwood

Jamie Ramsay

Numis Securities

020 7260 1000

Nick Westlake (NOMAD)

David Poutney, James Serjeant (Corporate Broker)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVIELIRLIS
Date   Source Headline
28th May 20265:04 pmRNSResult of AGM
1st May 20261:15 pmRNSNotice of ARA and AGM
27th Apr 202611:42 amRNSNotification of Major Holdings
21st Apr 20262:35 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSFinal Results
13th Apr 20261:31 pmRNSNotice of Investor Presentation
13th Apr 20261:29 pmRNSNotice of Results
31st Mar 20267:00 amRNSTotal Voting Rights
20th Mar 20264:17 pmRNSTotal Voting Rights
9th Mar 202612:36 pmRNS-REbiquity Appoints Head of Growth, Americas
6th Feb 202610:03 amRNS-REbiquity Strategic Leadership Appointment
22nd Jan 20267:00 amRNSTrading Update
24th Nov 202512:33 pmRNSTR-1: Notification of Major Holdings
21st Oct 20258:00 amRNS-REbiquity Joins Ad Context Protocol
15th Oct 20259:27 amRNSNotification of Major Holdings
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20251:22 pmRNS-RInvestor Presentation
1st Oct 20251:17 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSTrading Update
16th Sep 20257:00 amRNS-RNotice of Investor Presentation
2nd Sep 20257:00 amRNS-RLaunch of Advisory Board to Drive Strategic Growth
1st Sep 20257:00 amRNSBoard Changes
21st Aug 202511:53 amRNSNotification of Major Holdings
6th Aug 20258:30 amRNSTrading Update and Notice of Interim Results
29th Jul 202511:32 amRNSAllotment of Shares and Total Voting Rights
29th Jul 20259:22 amRNSBoard Appointments
24th Jun 20254:03 pmRNS-REbiquity Strengthens Americas Leadership
10th Jun 20257:00 amRNS-RAwarded Silver as a Top UK Media Consultancy
4th Jun 20255:24 pmRNSResult of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
2nd May 202511:59 amRNSAnnual Report and Notice of Annual General Meeting
22nd Apr 20257:00 amRNSFinal Results
10th Apr 20252:41 pmRNSNotice of Results
9th Apr 20257:00 amRNSNotification of major holdings
31st Mar 20254:33 pmRNSTotal Voting Rights
19th Mar 202510:00 amRNSHolding(s) in Company
19th Mar 202510:00 amRNSHolding(s) in Company
12th Mar 202510:46 amRNSIssue of Shares and TVR
3rd Mar 20257:00 amRNSAppointment of Chief Financial Officer
17th Feb 20257:00 amRNSAppointment of NOMAD and Trading Update
5th Dec 20247:00 amRNSTrading Update
19th Nov 20247:00 amRNSDirectorate Change
3rd Oct 20244:22 pmRNSTotal Voting Rights
30th Sep 20249:27 amRNSNotification of major holdings
26th Sep 20247:00 amRNSInterim Results
23rd Sep 20241:56 pmRNSNotification of major holdings
22nd Aug 202410:55 amRNSTrading Update and Notice of results
22nd Aug 20247:00 amRNSTrading Update and Notice of results
5th Aug 20247:00 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.